104 related articles for article (PubMed ID: 10201823)
21. Effect of sodium nitrite, primaquine, and menadione on TPN-methemoglobin reductase in vitro.
Tegeris AS
Toxicol Appl Pharmacol; 1966 Jan; 8(1):6-12. PubMed ID: 4380713
[No Abstract] [Full Text] [Related]
22. Methemoglobinogenic potential of primaquine and its mutagenicity in the Ames test.
Marrs TC; Bright JE; Morris BC
Toxicol Lett; 1987 May; 36(3):281-7. PubMed ID: 3296320
[TBL] [Abstract][Full Text] [Related]
23. Methemoglobin formation and reduction in canine erythrocytes characterized by inherited high Na+, K(+)-ATPase activity with normal and high glutathione concentrations.
Ogawa E; Horii Y; Honda M; Takahashi R
J Vet Med Sci; 1994 Oct; 56(5):873-7. PubMed ID: 7865586
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and antimalarial activity of novel, quinoline-based, zinc metallo-aminopeptidase inhibitors.
Flipo M; Florent I; Grellier P; Sergheraert C; Deprez-Poulain R
Bioorg Med Chem Lett; 2003 Aug; 13(16):2659-62. PubMed ID: 12873488
[TBL] [Abstract][Full Text] [Related]
25. [Synthesis of benzo(g)quinoline derivatives. XV. Di[benzo(g)-quinolylpiperazinyl]alkanes possessing antimalarial activity].
Kozyreva NP; Bekhli AF; Moshkovskiĭ ShD; Rabinovich SA; Makskovskaia EV
Med Parazitol (Mosk); 1981; 50(6):33-5. PubMed ID: 7033752
[No Abstract] [Full Text] [Related]
26. Synthesis and methemoglobin toxicity of the amides of 6/7 mono or disubstituted quinolone.
Srivastava S; Srivastava SK; Shukla A; Chauhan PM; Puri SK; Bhaduri AP; Pandey VC
Bioorg Med Chem Lett; 1999 Jan; 9(1):25-30. PubMed ID: 9990450
[TBL] [Abstract][Full Text] [Related]
27. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R
J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antimalarial evaluation of novel isocryptolepine derivatives.
Whittell LR; Batty KT; Wong RP; Bolitho EM; Fox SA; Davis TM; Murray PE
Bioorg Med Chem; 2011 Dec; 19(24):7519-25. PubMed ID: 22055713
[TBL] [Abstract][Full Text] [Related]
29. Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
Bonilla-Ramirez L; Rios A; Quiliano M; Ramirez-Calderon G; Beltrán-Hortelano I; Franetich JF; Corcuera L; Bordessoulles M; Vettorazzi A; López de Cerain A; Aldana I; Mazier D; Pabón A; Galiano S
Eur J Med Chem; 2018 Oct; 158():68-81. PubMed ID: 30199706
[TBL] [Abstract][Full Text] [Related]
30. Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum.
Bray PG; Deed S; Fox E; Kalkanidis M; Mungthin M; Deady LW; Tilley L
Biochem Pharmacol; 2005 Oct; 70(8):1158-66. PubMed ID: 16139253
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors.
Pannala M; Kher S; Wilson N; Gaudette J; Sircar I; Zhang SH; Bakhirev A; Yang G; Yuen P; Gorcsan F; Sakurai N; Barbosa M; Cheng JF
Bioorg Med Chem Lett; 2007 Nov; 17(21):5978-82. PubMed ID: 17827009
[TBL] [Abstract][Full Text] [Related]
32. Methemoglobin reduction under near physiological conditions.
Mansouri A
Biochem Med Metab Biol; 1989 Aug; 42(1):43-51. PubMed ID: 2775561
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and HMG CoA reductase inhibition of 4-thiophenyl quinolines as potential hypocholesterolemic agents.
Cai Z; Zhou W; Sun L
Bioorg Med Chem; 2007 Dec; 15(24):7809-29. PubMed ID: 17851082
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and aldose reductase-inhibitory activity of imidazopyrroloquinoline esters.
Urakami T; Tanaka A; Tanimoto T; Niki E
Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1493-7. PubMed ID: 8795268
[TBL] [Abstract][Full Text] [Related]
35. Primaquine-mediated oxidative metabolism in the human red cell. Lack of dependence on oxyhemoglobin, H2O2 formation, or glutathione turnover.
Kelman SN; Sullivan SG; Stern A
Biochem Pharmacol; 1982 Jul; 31(14):2409-14. PubMed ID: 7126253
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro antimalarial activity of a series of bisquinoline and bispyrrolo[1,2a]quinoxaline compounds.
van Heerden L; Cloete TT; Breytenbach JW; de Kock C; Smith PJ; Breytenbach JC; N'Da DD
Eur J Med Chem; 2012 Sep; 55():335-45. PubMed ID: 22889556
[TBL] [Abstract][Full Text] [Related]
37. Effect of repetitive bleeding on NADH-cytochrome b5 methemoglobin reductase activity and molybdenum content in erythrocytes in rats.
Yang Y; Wang F; Li GS; Kang DR
Biomed Environ Sci; 1996 Dec; 9(4):393-8. PubMed ID: 8988808
[TBL] [Abstract][Full Text] [Related]
38. Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines.
Kwiek JJ; Haystead TA; Rudolph J
Biochemistry; 2004 Apr; 43(15):4538-47. PubMed ID: 15078100
[TBL] [Abstract][Full Text] [Related]
39. [Dependence of human erythrocyte methemoglobin reductase on temperature].
Kozlova NM; Chernitskiĭ EA
Biokhimiia; 1991 Feb; 56(2):342-5. PubMed ID: 1873346
[TBL] [Abstract][Full Text] [Related]
40. Influence of antimalarials chloroquine, quinine, primaquine and mepacrine on the evolution of Ehrlich ascites tumour.
Castelli M; Baggio G; Ruberto AI; Tampieri A; Tartoni PL; Rossi T; Bossa MR; Galatulas I
Anticancer Res; 1996; 16(5A):2673-5. PubMed ID: 8917368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
